Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Arrowhead Pharma (NQ: ARWR )

80.74 USD -2.12 (-2.56%)
Official Closing Price Updated: 6:46 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Arrowhead Pharma

< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Arrowhead Pharmaceuticals Files IND for Phase 1b Study of ARO-HIF2 for Treatment of Clear Cell Renal Cell Carcinoma
Arrowhead Pharmaceuticals Files IND for Phase 1b Study of ARO-HIF2 for Treatment of Clear Cell Renal Cell Carcinoma 
From Business Wire News Releases
3 Stocks That Could Be the Next Biotech Buyouts
They have what deep-pocketed pharmaceutical giants want. 
Tags BPMC DCPH ARWR
From Motley Fool
Why This Pharmaceutical Stock Broke Out Bullishly In Early Action
SNY stock broke out Tuesday after pharmaceutical company unveiled a plan to restructure its agreement with Regeneron Pharmaceuticals. Sanofi will also restructure its business. 
From Investor's Business Daily
Arrowhead Pharmaceuticals Closes Underwritten Public Offering with Gross Proceeds of $266.8 Million
Arrowhead Pharmaceuticals Closes Underwritten Public Offering with Gross Proceeds of $266.8 Million 
From Business Wire News Releases
Despite Massive Gains This Year, This Biotech Stock Is a Risky Bet
Despite Arrowhead Pharmaceuticals' trouncing the market this year, there's one glaring weakness in its investment thesis at the moment. 
Tags JNJ Market News ARWR
From Motley Fool
38 Stocks Moving In Wednesday's Mid-Day Session
Gainers Ibio Inc (NYSE: IBIO) shares surged 47.8% to $0.2778 on continued momentum after the company joined the manufacturing ... 
Tags IBIO RVNC DT
From Benzinga
Here's Why Arrowhead Pharmaceuticals Is Tumbling Today
Now that the initial excitement has worn off, investors are correctly responding to the news of a public stock offering. 
Tags JNJ ALNY ARWR
From Motley Fool
IJR, PTBD: Big ETF Inflows
Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel, the biggest inflow was seen in the iShares Core S&P Small-Cap ETF (IJR), which added 7,400,000 units, or... 
Tags ETFs
From ETF Channel
12 Healthcare Stocks Moving In Wednesday's Pre-Market Session
Gainers Anavex Life Sciences, Inc. (NASDAQ: AVXL) stock surged 14.0% to $2.69 during Wednesday's pre-market session. The ... 
Tags Pre/Market Outlook Healthcare Stocks Pre/Market Movers PTGX
From Benzinga
26 Stocks Moving in Wednesday's Pre-Market Session
Gainers Healthequity Inc (NASDAQ: HQY) shares rose 14.1% to $69.90 in pre-market trading after the company reported ... 
Tags Premarket Movers Pre/Market Outlook NTES
From Benzinga
Arrowhead Pharmaceuticals Announces Pricing of Underwritten Public Offering of Common Stock
Arrowhead Pharmaceuticals Announces Pricing of Underwritten Public Offering of Common Stock 
From Business Wire News Releases
63 Biggest Movers From Yesterday
Gainers Audentes Therapeutics Inc (NASDAQ: BOLD) shares climbed 106% to close at $58.93 on Tuesday after the company agreed to be ... 
Tags TTEC Pre/Market Outlook Trading Ideas
From Benzinga
Here's Why Arrowhead Pharmaceuticals Is Soaring Today
Counterintuitively, investors are bidding up the share price after the company announced a public stock offering. 
Tags Market News ARWR
From Motley Fool
40 Stocks Moving In Tuesday's Mid-Day Session
Gainers Audentes Therapeutics Inc (NASDAQ: BOLD) shares jumped 105.9% to $58.90 after the company agreed to be acquired by ... 
Tags PTGX DOYU SGMO
From Benzinga
Does a Surprise Approval Make Alnylam Pharmaceuticals a Buy?
Investors were caught off guard when the genetic medicines company earned marketing approval for its second RNAi drug product sooner than expected. 
Tags MDCO DRNA Market News
From Motley Fool
Don't Waste Your Money on Penny Stocks; These 3 Companies Are Better Buys
There's gambling, and then there are these businesses with solid prospects you can invest in. 
Tags Market News IIPR ARWR
From Motley Fool
The Daily Biotech Pulse: Astellas To Buy Audentes For $3B, Applied Genetics Chief Medical Officer Quits, Axsome Aces Midstage Trial
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that ... 
Tags ARDX AQST KTOV
From Benzinga
19 Healthcare Stocks Moving In Tuesday's Pre-Market Session
Gainers Audentes Therapeutics, Inc. (NASDAQ: BOLD) shares rose 106.8% to $59.15 during Tuesday's pre-market session. The ... 
Tags QURE CLVS News
From Benzinga
22 Stocks Moving in Tuesday's Pre-Market Session
Gainers Audentes Therapeutics Inc (NASDAQ: BOLD) shares rose 106.2% to $59.00 in pre-market trading after the company agreed to be ... 
Tags Trading Ideas BOLD TTEC
From Benzinga
75 Biggest Movers From Yesterday
Gainers Kodiak Sciences Inc. (NASDAQ: KOD) shares jumped 72.5% to close at $51.05 on Monday after the company reported the sale ... 
Tags Health Care HEBT CANF
From Benzinga
8 Stocks To Watch For December 3, 2019
Some of the stocks that may grab investor focus today are: Wall Street expects Lands' End, Inc. (NASDAQ: LE) to report ... 
Tags Stocks to Watch MRVL Pre/Market Outlook
From Benzinga
This Highly Rated Biotech Company Just Tumbled 13% On A Public Offering
Arrowhead Pharmaceuticals announced an underwritten offer for 4 million shares late Monday, causing ARWR stock to collapse before the close. ARWR stock is a highly rated biotech company. 
From Investor's Business Daily
Arrowhead Pharmaceuticals Announces Proposed Underwritten Offering of Common Stock
Arrowhead Pharmaceuticals Announces Proposed Underwritten Offering of Common Stock 
From Business Wire News Releases
3 Soaring Biotech Stocks to Watch in December
Here's how they could keep on rocketing higher. 
Tags ADVM ARQL JNJ
From Motley Fool
This Biotech With 456% Growth In 2019 Just Gained A Price-Target Boost
Arrowhead Pharmaceuticals grabbed an upgrade Friday as ARWR stock has rocketed 144% since October on enthusiasm for the biotech company's RNAi platform. ARWR stock is 87% above a buy point. 
From Investor's Business Daily
7 Biggest Price Target Changes For Friday
SunTrust Robinson Humphrey boosted the price target for Apartment Investment and Management Company (NYSE: AIV) from $50 to $54. ... 
Tags RLJ RHP Price Target Changes
From Benzinga
Should You Sell or Hold a Stock after a 6X Gain in Two Days?
Karuna Therapeutics Tests Our Theories! 
Tags ARWR KRTX AZN
From Motley Fool
Stocks That Hit 52-Week Highs On Wednesday
Before 10 a.m. ET on Wednesday, 180 companies set new 52-week highs. Noteworthy Mentions: Microsoft (NASDAQ: MSFT) was the ... 
Tags SDGCF RDN CUE
From Benzinga
The Daily Biotech Pulse: Tonix Says No Surprises In FDA Meeting Minutes, Aravive Offering, FDA Nod For Qiagen
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags CCXI VRTX MTFB
From Benzinga
60 Biggest Movers From Yesterday
Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) shares climbed 281.3% to close at $30.73 on Tuesday after the company announced the ... 
Tags ORMP XENE MTSC
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.